Premium
Single Dose Prophylactic Antibiotics in Caesarean Sections
Author(s) -
Chan A.C.W.,
Leung A.K.L.,
Chin R.K.H.,
Chang A.M. Z.
Publication year - 1989
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1989.tb01696.x
Subject(s) - ampicillin , sulbactam , medicine , metronidazole , placebo , obstetrics and gynaecology , randomized controlled trial , caesarean section , antibiotics , obstetrics , anesthesia , surgery , pregnancy , alternative medicine , antibiotic resistance , genetics , pathology , imipenem , microbiology and biotechnology , biology
Summary: A prospective, double‐blind randomized trial was carried out at the Department of Obstetrics and Gynaecology, the Chinese University of Hong Kong, involving 4 groups of patients receiving a single intravenous dose of placebo, ampicillin, ampicillin and metronidazole, and ampicillin and sulbactam before operation. No difference in postoperative morbidity was present between the 4 groups of patients.